Susquehanna International Group’s AMAG Pharmaceuticals AMAG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-210,900
| Closed | -$1.98M | – | 12073 |
|
|
2020
Q3 | $1.98M | Buy |
210,900
+58,800
| +39% | +$559K | ﹤0.01% | 4643 |
|
|
2020
Q2 | $1.16M | Sell |
152,100
-1,600
| -1% | -$12.2K | ﹤0.01% | 5574 |
|
|
2020
Q1 | $950K | Sell |
153,700
-129,000
| -46% | -$1.14M | ﹤0.01% | 5534 |
|
|
2019
Q4 | $3.44M | Buy |
282,700
+40,100
| +17% | +$438K | ﹤0.01% | 3487 |
|
|
2019
Q3 | $2.8M | Buy |
242,600
+84,400
| +53% | +$888K | ﹤0.01% | 3604 |
|
|
2019
Q2 | $1.58M | Buy |
158,200
+78,600
| +99% | +$848K | ﹤0.01% | 4649 |
|
|
2019
Q1 | $1.02M | Buy |
79,600
+11,600
| +17% | +$173K | ﹤0.01% | 5006 |
|
|
2018
Q4 | $1.03M | Sell |
68,000
-55,400
| -45% | -$1.06M | ﹤0.01% | 4600 |
|
|
2018
Q3 | $2.47M | Sell |
123,400
-76,000
| -38% | -$1.73M | ﹤0.01% | 3666 |
|
|
2018
Q2 | $3.89M | Buy |
199,400
+36,300
| +22% | +$803K | ﹤0.01% | 3039 |
|
|
2018
Q1 | $3.29M | Buy |
163,100
+13,000
| +9% | +$220K | ﹤0.01% | 3117 |
|
|
2017
Q4 | $1.99M | Buy |
150,100
+77,400
| +106% | +$1.17M | ﹤0.01% | 3921 |
|
|
2017
Q3 | $1.34M | Sell |
72,700
-19,000
| -21% | -$354K | ﹤0.01% | 4698 |
|
|
2017
Q2 | $1.69M | Sell |
91,700
-55,100
| -38% | -$1.09M | ﹤0.01% | 4227 |
|
|
2017
Q1 | $3.31M | Buy |
146,800
+59,800
| +69% | +$1.43M | ﹤0.01% | 2885 |
|
|
2016
Q4 | $3.03M | Buy |
87,000
+68,700
| +375% | +$2.05M | ﹤0.01% | 3222 |
|
|
2016
Q3 | $449K | Sell |
18,300
-9,600
| -34% | -$240K | ﹤0.01% | 6272 |
|
|
2016
Q2 | $667K | Buy |
+27,900
| New | +$640K | ﹤0.01% | 5622 |
|
|
2014
Q4 | – | Sell |
-15,900
| Closed | -$507K | – | 10286 |
|
|
2014
Q3 | $507K | Buy |
15,900
+900
| +6% | +$19.2K | ﹤0.01% | 7185 |
|
|
2014
Q2 | $311K | Sell |
15,000
-22,900
| -60% | -$423K | ﹤0.01% | 8325 |
|
|
2014
Q1 | $733K | Buy |
+37,900
| New | +$805K | ﹤0.01% | 6066 |
|
|
2013
Q4 | – | Sell |
-35,500
| Closed | -$763K | – | 9488 |
|
|
2013
Q3 | $763K | Sell |
35,500
-500
| -1% | -$11.8K | ﹤0.01% | 5749 |
|
|
2013
Q2 | $801K | Buy |
+36,000
| New | +$793K | ﹤0.01% | 5352 |
|
Susquehanna International Group's AMAG Position: Q2 2020 in Review
Susquehanna International Group sold out of AMAG Pharmaceuticals (AMAG) in Q2 2020, closing a stake of 29,134 shares — an estimated $223K sold.
Susquehanna International Group first reported a position in AMAG in Q2 2014 and held it in 16 quarters. The position peaked at $21.3M in Q2 2015. 119 funds tracked by Wall St. Rank hold AMAG as of Q2 2020.
- Susquehanna International Group reported no remaining AMAG Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
- Susquehanna International Group sold 29,134 AMAG Pharmaceuticals shares in Q2 2020, an estimated $223K.
- Susquehanna International Group first reported a position in AMAG Pharmaceuticals in Q2 2014 and held it in 16 quarters.
- Susquehanna International Group's AMAG Pharmaceuticals position peaked at $21.3M in Q2 2015.
- 119 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q2 2020.
Based on Susquehanna International Group's 13F filing for Q2 2020, filed 14 Aug 2020.